Welcome to the Working Group on New TB Drugs Blog
CNN News Coverage and FIND Presentation on Rapid TB test, Xpert MTB/RIF
CNN featured TB diagnostic Xpert MTB/RIF in its Inside Africa program and looked at the implementation of Xpert MTB/RIF in Uganda. In addition, the CORE Group hosted an online presentation on Xpert MTB/RIF from Elizabeth Talbot, Associate Professor of Infectious Diseases and International Health at Dartmouth Hitchcock Medical Center, and Medical Scientist, FIND: Foundation for Innovative New Diagnostics. Results of a survey of their TB Working Group listserv also is included.
USAID Head: TB Drug Research Critical in Turning Tide Against Epidemic
Dr. Rajiv Shah, Administrator of the United States Agency for International Development (USAID) presented the most recent David E. Barmes Global Health Lecture on Tuesday, February 15, 2011 on the NIH Campus in Bethesda, Maryland.
Interview with Dr. Anneke Hesseling – Part Three
An interview with Dr. Anneke Hesseling, the Director of the Paediatric TB Research Program at the Desmond Tutu TB Centre at Stellenbosch University in Cape Town, South Africa.
Interview with Dr. Anneke Hesseling – Part Two
An interview with Dr. Anneke Hesseling, the Director of the Paediatric TB Research Program at the Desmond Tutu TB Centre at Stellenbosch University in Cape Town, South Africa.
Interview with Dr. Anneke Hesseling – Part One
An interview with Dr. Anneke Hesseling, the Director of the Paediatric TB Research Program at the Desmond Tutu TB Centre at Stellenbosch University in Cape Town, South Africa.
First Novel Regimen Clinical Trial Featured on South African TB
The clinical trial of the first novel regimen was featured today on SABC TV in South Africa. This is the first clinical trial to test multiple new TB drugs in combination; the trial is known as New Combination 1 (NC001). The experimental regimen undergoing testing in this trial consists of experimental TB drugs PA-824, Moxifloxacin, and Pyrazinamide, an antibiotic commonly administered as part of current TB treatment.
TB Alliance Launches First Clinical Trial of a Novel TB Drug Regimen
Today, the TB Alliance announced the first clinical trial to test multiple new TB drugs in combination; the trial is known as New Combination 1 (NC001).The experimental regimen undergoing testing in this trial consists of experimental TB drugs PA-824, Moxifloxacin, and Pyrazinamide, an antibiotic commonly administered as part of current TB treatment. This regimen has shown potential to harmonize treatment for TB drug-sensitive tuberculosis (DS-TB) and multidrug-resistant tuberculosis (MDR-TB) under a single three-drug regimen.
MSF Podcast: Difficulties of Treating Children with TB
From MSF: In Mathare, a poor area on the outskirts of Nairobi, MSF treats children with TB, but just diagnosing them is extremely challenging. Results of the lack of research into TB means the main diagnostic tool for the adult form of the disease is 130 years old and not at all adapted for use with children.
-
You are currently browsing the archives for the Video category.
-
Toppix TB News- Calif. Man Is Criminally Charged to Force Compliance with Tuberculosis Treatment Plan 18 May 2012
- Indian Hospital patients share stories to help heal 17 May 2012
- West Springfield women honored for working with immigrants to prevent tuberculosis 15 May 2012
- MSF says additional resources needed to improve ART access in Burma 11 May 2012
- World disease fund gets added $1.6 bln shot in arm 9 May 2012
